CTSA Resources


NIH Scientific Data Sharing This new public-facing website is a central portal for resources on NIH sharing policies and provides information to help address common questions, such as which NIH sharing policies apply to a particular research project, how to share and submit data, how to access data from NIH-supported repositories, and more.
N3C N3C is a partnership among the NCATS-supported Clinical and Translational Science Awards (CTSA) Program hubs and the National Center for Data to Health (CD2H). Collaborators will contribute and use COVID-19 clinical data to answer critical research questions to address the pandemic.

CTSA CCOS – Coordination, Communications, and Operations Support. The CTSA Program is designed to develop innovative solutions that will improve the efficiency, quality and impact of the process for turning observations in the laboratory, clinic and community into interventions that improve the health of individuals and the public.

CD2H The CTSA National Center for Data to Health (CD2H) accelerates advancements in informatics by utilizing findable, accessible, interoperable, and reusable (FAIR) principles to promote collaboration across the Clinical and Translational Science Awards (CTSA) Program community.
NCATS The National Center for Advancing Translational Sciences (NCATS) was established to transform the translational process so that new treatments and cures for disease can be delivered to patients faster.
REDCap REDCap is a secure web application for building and managing online surveys and databases and is specifically geared to support online and offline data capture for research studies and operations.
SMART IRB SMART IRB is a platform designed to ease common challenges associated with initiating multisite research and to provide a roadmap for institutions to implement the NIH Single IRB Review policy.
Trial Innovation Network The Trial Innovation Network is a new collaborative initiative within NCATS’ CTSA Program. NCATS’ vision for the Trial Innovation Network is to address critical roadblocks in clinical trials and to accelerate the translation of novel interventions into life-saving therapies.